Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Jun 1;99(6):513-520.
doi: 10.1097/OPX.0000000000001901. Epub 2022 Apr 12.

Rasch-calibrated Intermittent Exotropia Symptom Questionnaire for Children

Affiliations
Randomized Controlled Trial

Rasch-calibrated Intermittent Exotropia Symptom Questionnaire for Children

Jonathan M Holmes et al. Optom Vis Sci. .

Abstract

Significance: A rigorously designed and calibrated symptom questionnaire for childhood intermittent exotropia would be useful for clinical care and for research.

Purpose: The aim of this study was to Rasch-calibrate and evaluate the previously developed Child Intermittent Exotropia Symptom Questionnaire using data gathered as part of a randomized clinical trial.

Methods: The questionnaire was administered to 386 children aged 3 to 10 years with intermittent exotropia who were enrolled in a randomized clinical trial comparing overminus with nonoverminus spectacles. Participants were followed at 6 and 12 months while on treatment and at 18 months off treatment. Factor analysis determined dimensionality, and Rasch analysis evaluated questionnaire performance. Logit values were converted to 0 (best) to 100 (worst). We evaluated differences in questionnaire scores between treatment groups and time points, and correlations with control scores.

Results: The Child Intermittent Exotropia Symptom Questionnaire was unidimensional. Rasch analysis indicated that there was no notable local dependence and no significant differential item functioning for sex or age. There was suboptimal targeting (mean logit, -1.62), and person separation was somewhat poor (0.95). There were no significant differences in the Child Intermittent Exotropia Symptom score between overminus spectacles and nonoverminus spectacles at 6, 12, and 18 months. Combining data from both treatment groups, there was significant improvement from baseline at all follow-up visits (e.g., mean change from baseline to 12 months, -6.6 points; 95% confidence interval, -8.6 to -4.6). Child Intermittent Exotropia Symptom scores were not correlated with distance or near control scores at 12 months.

Conclusions: The seven-item Rasch-scored Child Intermittent Exotropia Symptom Questionnaire is limited by suboptimal performance. Future study is needed to determine whether it may be useful for clinical practice and for research.

Trial registration: ClinicalTrials.gov NCT02807350.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosure: None of the authors have reported a financial conflict of interest.

Figures

Figure 1.
Figure 1.
Child Intermittent Exotropia Symptom Questionnaire. The 7-item questionnaire was administered to children ages 3 to <7 years by study personnel or self-administered by children 7 to 10 years old, with assistance from study personnel if needed. Response options for each question were “never,” “sometimes,” and “all the time.”
Figure 2.
Figure 2.
Category Thresholds / Category Probability Curves. Category threshold / category probability curves illustrate proper ordering of response categories and utilization of response options.
Figure 3.
Figure 3.
Targeting of the Child Intermittent Exotropia (IXT) Symptom Questionnaire. Targeting was suboptimal for the Child IXT Symptom Questionnaire, noting position of mean (M) of respondents on left of figure and questions on right of figure (mean difference −1.62 logits).
Figure 4.
Figure 4.
Relationship of Child Intermittent Exotropia (IXT) Symptom Score with Distance Control at 12 Months. Scatter plot of distance control at 12 months versus child IXT symptom score at 12 months. The Spearman correlation coefficient, calculated on the logit scale, was −0.04 (95% CI −0.15, 0.07), indicating no correlation; results were similar at all other visits.
Figure 5.
Figure 5.
Relationship of Child Intermittent Exotropia (IXT) Symptom Score with Near Control at 12 Months.Scatter plot of near control at 12 months versus child IXT symptom score at 12 months. The Spearman correlation coefficient, calculated on the logit scale, was 0.08 (95% CI −0.03, 0.18), indicating no correlation; results were similar for other visits.

References

    1. Braithwaite T, Calvert M, Gray A, et al. The Use of Patient-Reported Outcome Research in Modern Ophthalmology: Impact on Clinical Trials and Routine Clinical Practice. Patient Relat Outcome Meas 2019;10:9–24. - PMC - PubMed
    1. Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims: Draft Guidance. Health Qual Life Outcomes 2006;4:79. - PMC - PubMed
    1. Hatt SR, Leske DA, Liebermann L, Holmes JM. Symptoms in Children with Intermittent Exotropia and Their Impact on Health-Related Quality of Life. Strabismus 2016;24:139–45. - PMC - PubMed
    1. Hatt SR, Leske DA, Yamada T, et al. Development and Initial Validation of Quality-of-Life Questionnaires for Intermittent Exotropia. Ophthalmology 2010;117:163–8.e1. - PMC - PubMed
    1. Chen AM, Erzurum SA, Chandler DL, et al. Overminus Lens Therapy for Children 3 to 10 Years of Age with Intermittent Exotropia: A Randomized Clinical Trial. JAMA Ophthalmol 2021;139:464–76. - PMC - PubMed

Publication types

Associated data